Vascular endothelial growth factor (VEGF) delivery approaches in regenerative medicine

被引:25
作者
Beheshtizadeh, Nima [1 ,3 ,7 ]
Gharibshahian, Maliheh [2 ,3 ]
Bayati, Mohammad [4 ]
Maleki, Reza [5 ]
Strachan, Hannah [6 ]
Doughty, Sarah [6 ]
Tayebi, Lobat [6 ]
机构
[1] Univ Tehran Med Sci, Sch Adv Technol Med, Dept Tissue Engn, Tehran, Iran
[2] Shahroud Univ Med Sci, Sch Med, Dept Tissue Engn, Shahroud, Iran
[3] Universal Sci Educ & Res Network USERN, Regenerat Med Grp REMED, Tehran, Iran
[4] Shahid Beheshti Univ, Med Plants & Drugs Res Inst, Dept Phytochem, Tehran, Iran
[5] Iranian Res Org Sci & Technol IROST, Dept Chem Technol, POB 33535111, Tehran, Iran
[6] Marquette Univ, Sch Dent, Milwaukee, WI 53233 USA
[7] 88 Italia St,Qods Ave,Keshavarz Blvd, Tehran 1417755469, Iran
基金
美国国家卫生研究院;
关键词
VEGF; Drug delivery; Growth factor; Angiogenesis; Regenerative medicine; IN-VITRO CHARACTERIZATION; DRUG-DELIVERY; CONTROLLED-RELEASE; SUSTAINED-RELEASE; GENE-THERAPY; POLYMERIC NANOPARTICLES; MICROFLUIDIC SYNTHESIS; ENHANCES ANGIOGENESIS; SEQUENTIAL DELIVERY; PLGA MICROPARTICLES;
D O I
10.1016/j.biopha.2023.115301
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The utilization of growth factors in the process of tissue regeneration has garnered significant interest and has been the subject of extensive research. However, despite the fervent efforts invested in recent clinical trials, a considerable number of these studies have produced outcomes that are deemed unsatisfactory. It is noteworthy that the trials that have yielded the most satisfactory outcomes have exhibited a shared characteristic, namely, the existence of a mechanism for the regulated administration of growth factors. Despite the extensive exploration of drug delivery vehicles and their efficacy in delivering certain growth factors, the development of a reliable predictive approach for the delivery of delicate growth factors like Vascular Endothelial Growth Factor (VEGF) remains elusive. VEGF plays a crucial role in promoting angiogenesis; however, the administration of VEGF demands a meticulous approach as it necessitates precise localization and transportation to a specific target tissue. This process requires prolonged and sustained exposure to a low concentration of VEGF. Inaccurate administration of drugs, either through off-target effects or inadequate delivery, may heighten the risk of adverse reactions and potentially result in tumorigenesis. At present, there is a scarcity of technologies available for the accurate encapsulation of VEGF and its subsequent sustained and controlled release. The objective of this review is to present and assess diverse categories of VEGF administration mechanisms. This paper examines various systems, including polymeric, liposomal, hydrogel, inorganic, polyplexes, and microfluidic, and evaluates the appropriate dosage of VEGF for multiple applications.
引用
收藏
页数:18
相关论文
共 232 条
[21]   HEPATOCYTE GROWTH-FACTOR IS A POTENT ANGIOGENIC FACTOR WHICH STIMULATES ENDOTHELIAL-CELL MOTILITY AND GROWTH [J].
BUSSOLINO, F ;
DIRENZO, MF ;
ZICHE, M ;
BOCCHIETTO, E ;
OLIVERO, M ;
NALDINI, L ;
GAUDINO, G ;
TAMAGNONE, L ;
COFFER, A ;
COMOGLIO, PM .
JOURNAL OF CELL BIOLOGY, 1992, 119 (03) :629-641
[22]   Microencapsulation of growth factors by microfluidic system [J].
Caballero-Aguilar, Lilith M. ;
Duchi, Serena ;
Quigley, Anita ;
Onofrillo, Carmine ;
Di Bella, Claudia ;
Moulton, Simon E. .
METHODSX, 2021, 8
[23]   Alginate hydrogels allow for bioactive and sustained release of VEGF-C and VEGF-D for lymphangiogenic therapeutic applications [J].
Campbell, Kevin T. ;
Hadley, Dustin J. ;
Kukis, David L. ;
Silva, Eduardo A. .
PLOS ONE, 2017, 12 (07)
[24]   Mechanisms of angiogenesis and arteriogenesis [J].
Carmeliet, P .
NATURE MEDICINE, 2000, 6 (04) :389-395
[25]   Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [J].
Carmeliet, P ;
Ferreira, V ;
Breier, G ;
Pollefeyt, S ;
Kieckens, L ;
Gertsenstein, M ;
Fahrig, M ;
Vandenhoeck, A ;
Harpal, K ;
Eberhardt, C ;
Declercq, C ;
Pawling, J ;
Moons, L ;
Collen, D ;
Risau, W ;
Nagy, A .
NATURE, 1996, 380 (6573) :435-439
[26]   α-Tricalcium phosphate: Synthesis, properties and biomedical applications [J].
Carrodeguas, R. G. ;
De Aza, S. .
ACTA BIOMATERIALIA, 2011, 7 (10) :3536-3546
[27]   Particle shape: A new design parameter for micro- and nanoscale drug delivery carriers [J].
Champion, Julie A. ;
Katare, Yogesh K. ;
Mitragotri, Samir .
JOURNAL OF CONTROLLED RELEASE, 2007, 121 (1-2) :3-9
[28]   Combined and sequential delivery of bioactive VEGF165 and HGF from poly (trimethylene carbonate) based photo-cross-linked elastomers [J].
Chapanian, R. ;
Amsden, B. G. .
JOURNAL OF CONTROLLED RELEASE, 2010, 143 (01) :53-63
[29]   Polymeric growth factor delivery strategies for tissue engineering [J].
Chen, RR ;
Mooney, DJ .
PHARMACEUTICAL RESEARCH, 2003, 20 (08) :1103-1112
[30]   Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation [J].
Chen, Ruth R. ;
Silva, Eduardo A. ;
Yuen, William W. ;
Mooney, David J. .
PHARMACEUTICAL RESEARCH, 2007, 24 (02) :258-264